rybelsus glp 1 Oral Semaglutide Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients Rybelsus is from the class of medicines called GLP Rybelsus (Oral Semaglutide) Prescription |
Description
I think the beneficial outcomes in patients who received metformin and were newly started on a GLP-1 suggest that there could be synergy between these two in patients with diabetes and cancer, Mahadevan said
He has received grant support from Merck and Sharp & Dohme
[DOI] [PubMed] [Google Scholar] 131.Lu F., Jin T., Drucker D.J
doi: 10.3390/molecules25081987, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar] 8
New England Journal of Medicine , 375 (19), 1834-1844
The study found that this class of medications significantly increases the risk of developing gastroparesis and other gastrointestinal disorders
